Cargando…

Ammonium tetrathiomolybdate in the decoppering phase treatment of Wilson's disease with neurological symptoms: A case series

OBJECTIVES: To present our experience with ammonium tetrathiomolybdate (ATTM) in the decoppering phase treatment of Wilson's disease (WD) with neurological symptoms. METHODS: An uncontrolled longitudinal study was carried out to describe a case series of five patients diagnosed of WD with neuro...

Descripción completa

Detalles Bibliográficos
Autores principales:	De Fabregues, Oriol, Viñas, Jaume, Palasí, Antoni, Quintana, Manuel, Cardona, Ignasi, Auger, Cristina, Vargas, Víctor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7218247/ https://www.ncbi.nlm.nih.gov/pubmed/32202078 http://dx.doi.org/10.1002/brb3.1596

Ejemplares similares

Ammonium tetrathiomolybdate treatment of copper‐associated hepatopathy in dogs
por: Langlois, Daniel K., et al.
Publicado: (2019)

Is Hydrogen Sulfide a Concern During Treatment of Lung Adenocarcinoma With Ammonium Tetrathiomolybdate?
por: Li, Xiang, et al.
Publicado: (2020)

Ammonium tetrathiomolybdate triggers autophagy-dependent NRF2 activation in vascular endothelial cells
por: Zhang, Mengling, et al.
Publicado: (2022)

Bis‐choline Tetrathiomolybdate as Old Drug in a New Design for Wilson’s Disease: Good for Brain and Liver?
por: Stremmel, Wolfgang
Publicado: (2018)

The copper chelator ammonium tetrathiomolybdate inhibits the progression of experimental endometriosis in TNFR1-deficient mice
por: Conforti, Rocío Ayelem, et al.
Publicado: (2023)

Ammonium tetrathiomolybdate treatment targets the copper transporter ATP7A and enhances sensitivity of breast cancer to cisplatin
por: Chisholm, Cristine L., et al.
Publicado: (2016)

Neuroprotective effects of ammonium tetrathiomolybdate, a slow-release sulfide donor, in a rodent model of regional stroke
por: Mendonça, Bruna Pescador, et al.
Publicado: (2020)

Ammonium tetrathiomolybdate relieves oxidative stress in cisplatin-induced acute kidney injury via NRF2 signaling pathway
por: Qi, Hao, et al.
Publicado: (2023)

Ammonium tetrathiomolybdate following ischemia/reperfusion injury: Chemistry, pharmacology, and impact of a new class of sulfide donor in preclinical injury models
por: Dyson, Alex, et al.
Publicado: (2017)

Ammonium tetrathiomolybdate enhances the antitumor effect of cisplatin via the suppression of ATPase copper transporting beta in head and neck squamous cell carcinoma
por: Ryumon, Shoji, et al.
Publicado: (2019)

Neurologic Wilson disease: case series on a diagnostic and therapeutic emergency
por: Porlas Jr, Romeo V., et al.
Publicado: (2018)

Linear structural features of Wilson’s disease and its correlation with neurological symptoms
por: Diao, Sheng-Peng, et al.
Publicado: (2022)

Psychiatric Symptoms sans Hepato-Neurological symptoms in Wilson Disease – A case Report
Publicado: (2022)

Neurodegeneration in Hepatic and Neurologic Wilson’s Disease
por: Viveiros, André, et al.
Publicado: (2021)

Neurological Phenotype of Mowat-Wilson Syndrome
por: Cordelli, Duccio Maria, et al.
Publicado: (2021)

Tetrathiomolybdate induces dimerization of the metal-binding domain of ATPase and inhibits platination of the protein
por: Fang, Tiantian, et al.
Publicado: (2019)

Selective elimination of neuroblastoma cells by synergistic effect of Akt kinase inhibitor and tetrathiomolybdate
por: Navrátilová, Jarmila, et al.
Publicado: (2017)

Bis-choline tetrathiomolybdate prevents copper-induced blood–brain barrier damage
por: Borchard, Sabine, et al.
Publicado: (2021)

Analysis of risk factors for neurological symptoms in patients with purely hepatic Wilson’s disease at diagnosis
por: Diao, Sheng-Peng, et al.
Publicado: (2023)

Copper chelation with tetrathiomolybdate suppresses adjuvant-induced arthritis and inflammation-associated cachexia in rats
por: Omoto, Atsushi, et al.
Publicado: (2005)

Tetrathiomolybdate Decreases the Expression of Alkaline Phosphatase in Dermal Papilla Cells by Increasing Mitochondrial ROS Production
por: Li, Fan, et al.
Publicado: (2023)

Characteristics of neurological Wilson’s disease with corpus callosum abnormalities
por: Zhou, Zhi-Hua, et al.
Publicado: (2019)

Predictors of caregiver burden in patients with neurologic Wilson disease
por: Wu, Peng, et al.
Publicado: (2020)

Tetrathiomolybdate sensitizes ovarian cancer cells to anticancer drugs doxorubicin, fenretinide, 5-fluorouracil and mitomycin C
por: Kim, Kyu Kwang, et al.
Publicado: (2012)

Tetrathiomolybdate Treatment Attenuates Bleomycin-Induced Angiogenesis and Lung Pathology in a Sheep Model of Pulmonary Fibrosis
por: Derseh, Habtamu B., et al.
Publicado: (2021)

Analyzing the Therapeutic Efficacy of Bis-Choline-Tetrathiomolybdate in the Atp7b(−/−) Copper Overload Mouse Model
por: Kim, Philipp, et al.
Publicado: (2021)

Effective Treatment of Neurological Symptoms with Normal Doses of Botulinum Neurotoxin in Wilson’s Disease: Six Cases and Literature Review
por: Hefter, Harald, et al.
Publicado: (2021)

Wilson disease in pregnancy: A case series
por: Xiong, Xiali, et al.
Publicado: (2023)

Neurological Manifestations of Wilson's Disease: Pathophysiology and Localization of Each Component
por: Ortiz, Juan Fernando, et al.
Publicado: (2020)

Neurological Wilson’s Disease Signs—Hepatic Encephalopathy or Copper Toxicosis?
por: Jopowicz, Anna, et al.
Publicado: (2023)

Clinical and Genetic Analysis in Neurological Wilson’s Disease Patients With Neurological Worsening Following Chelator Therapy
por: Hou, Haiman, et al.
Publicado: (2022)

Identification of biomarkers for the antiangiogenic and antitumour activity of the superoxide dismutase 1 (SOD1) inhibitor tetrathiomolybdate (ATN-224)
por: Doñate, F, et al.
Publicado: (2008)

Tetrathiomolybdate inhibits mitochondrial complex IV and mediates degradation of hypoxia-inducible factor-1α in cancer cells
por: Kwang Kim, Kyu, et al.
Publicado: (2015)

Acute onset neurological symptoms in Wilson disease after traumatic, surgical or emotional events: A cross-sectional study
por: Li, Liang-Yong, et al.
Publicado: (2019)

Emerging neurological symptoms after liver transplantation: A 6‐year follow‐up of an adolescent patient with Wilson’s disease
por: Xu, Wan‐Qing, et al.
Publicado: (2022)

Endocrine Symptoms as the Initial Manifestation of Wilson’s Disease
por: Krysiak, Robert, et al.
Publicado: (2012)

Brain volume is related to neurological impairment and to copper overload in Wilson’s disease
por: Smolinski, Lukasz, et al.
Publicado: (2019)

Plasma Neurofilament Light as a Biomarker of Neurological Involvement in Wilson's Disease
por: Shribman, Samuel, et al.
Publicado: (2020)

Neurological-Type Wilson Disease: Epidemiology, Clinical Manifestations, Diagnosis, and Management
por: Kipker, Nathaniel, et al.
Publicado: (2023)

Wilson’s disease in pregnancy: case series and review of literature
por: Malik, Ayesha, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_oe98nbrn14iqdfkqgaa3qjshtn